NCM · Biotechnology

VERU (VERU) Stock

$2.36 +2.17% NCM: VERU Healthcare

Valuation

MetricValue
Price$2.36
Market Cap$37.88M
P/E Ratio-2.03
P/B Ratio1.93
P/S Ratio0.00
EPS (TTM)$-1.07
52-Week High$7.33
52-Week Low$2.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-127.78%
ROA-76.67%
ROCE-138.89%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.08
Current Ratio2.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$61.0M$39.0M$16.0M$17.0M$0
Operating Profit$13.0M$-83.0M$-94.0M$-37.0M$-25.0M
Net Profit$7.0M$-84.0M$-93.0M$-38.0M$-23.0M
EPS$0.88$-10.49$-10.96$-2.80$-1.07
Op Margin21.2%-211.5%-575.5%-218.6%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$178.0M$135.0M$50.0M$60.0M$30.0M
Total Liabilities$26.0M$53.0M$30.0M$28.0M$12.0M
Cash$122.0M$80.0M$10.0M$25.0M$16.0M
Borrowings$14.0M$16.0M$14.0M$14.0M$3.0M

Latest News

Foresee Pharmaceuticals Appoints Brian J. Groch as Chief Commercial Officer to Spearhead Commercial Launch of FP-001 42 mg for Central Precocious Puberty PR Newswire · Jul 9, 2026 Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day GlobeNewswire · Jul 7, 2026 Veru And 2 Other Intriguing Penny Stocks To Watch Simply Wall St. · Jun 5, 2026 Novo Nordisk Tests Wegovy Combinations In Older Adults With Veru Trial Simply Wall St. · Jun 5, 2026 This Small-Cap Biotech Just Soared Over 160% — What Is The Novo Nordisk Connection? Stocktwits · Jun 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-16.0M$-48.0M$-88.0M$-22.0M$-30.0M
Investing Cash Flow$14.0M$4.0M$6.0M$0$25.0M
Financing Cash Flow$2.0M$0$5.0M$2.0M$0
Net Cash Flow$109.0M$-42.0M$-71.0M$15.0M$-9.0M
Free Cash Flow$-16.0M$-48.0M$-89.0M$-22.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-74.82%
Quick Ratio6.19
Interest Coverage—
Return 1Y-59.22%
Return 3Y-80.61%
Return 5Y-96.59%

Ownership

Insiders Held9.78%
Institutions Held24.58%
Institutions Float Held27.24%
Institutional HolderSharesReport Date
Alyeska Investment Group, L.p.1,000,0002026-03-31
Vanguard Capital Management LLC539,3822026-03-31
Oppenheimer & Co Inc196,3002026-03-31
GSA Capital Partners LLP189,6992026-03-31
Geode Capital Management, LLC184,6222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANVS $1.70 +0.59% -1.54 $33.45M 0.00%
BCABBioAtla, Inc. $3.40 +0.89% -0.08 $4.29M 0.00%
BTAIBioXcel Therapeutics, Inc. $0.87 +2.30% -0.13 $26.77M 0.00%
CELUCelularity Inc. $0.75 +0.13% -0.20 $21.74M 0.00%
DYAIDyadic International, Inc. $1.17 -1.68% -5.59 $42.63M 0.00%

About VERU

VERU is led by CEO Mitchell S. Steiner, employs 210 people, headquartered in US, publicly traded since 1999.

VERU stock trades at $2.36 with a market capitalization of $37.88M. The stock is valued at a price-to-earnings (P/E) ratio of -2.03, price-to-book of 1.93, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.05 and $7.33, and currently trades 67.8% below its 52-week high.

On profitability, VERU generates a return on equity (ROE) of -127.78%, return on capital employed of -138.89%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides